Dupilumab in the Treatment of Pediatric Alopecia Areata
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Dupilumab
Related studies linked through entity extraction aliases.
Molecular Signatures of Cutaneous Dupilumab Response
- Status
- RECRUITING
- Phase
- PHASE4
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Mind and Skin - the Neurocutaneous Axis in Atopic Eczema
- Status
- RECRUITING
- Phase
- N/A
Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dupilumab Effects Against Aeroallergen Challenge
- Status
- RECRUITING
- Phase
- PHASE2
Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid
- Status
- COMPLETED
- Phase
- N/A
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial
- Status
- COMPLETED
- Phase
- PHASE4
Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Regeneron AA Multicenter (Dupilumab)
- Status
- RECRUITING
- Phase
- PHASE2
Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)
- Status
- TERMINATED
- Phase
- PHASE3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)
- Status
- COMPLETED
- Phase
- PHASE3
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
- Status
- COMPLETED
- Phase
- PHASE4
IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1